|
6 Companies |
|
2 Products |
|
2 Products |
|
0 Mechanisms of Action |
|
0 Trials |
|
7 News |
|
- | lorazepam / Generic mfg., dexmedetomidine / Generic mfg.
Clinical: Dexmedetomidine (Precedex®) for Severe Alcohol Withdrawal Syndrome (AWS) and Alcohol Withdrawal Delirium (AWD) (clinicaltrials.gov) - Apr 18, 2017
P4, N=49, Terminated, Sponsor: Denver Health and Hospital Authority
Trial primary completion date: Mar 2017 --> Dec 2015
- Wakix (pitolisant) / Ferrer International, Paragon Biosci
Enrollment change, Trial withdrawal: A Trial Evaluating Pitolisant (BF2.649) in Alcohol Use Disorder Treatment (clinicaltrials.gov) - Jan 12, 2017
P2, N=0, Withdrawn, Sponsor: Bioprojet
Trial primary completion date: Mar 2017 --> Dec 2015 N=569 --> 0 | Not yet recruiting --> Withdrawn
- ||||| Wakix (pitolisant) / Ferrer International, Paragon Biosci
New P2 trial: A Trial Evaluating Pitolisant (BF2.649) in Alcohol Use Disorder Treatment (clinicaltrials.gov) - Jun 16, 2016
P2, N=569, Not yet recruiting, Sponsor: Bioprojet
- lorazepam / Generic mfg., dexmedetomidine / Generic mfg.
Clinical: Dexmedetomidine (Precedex®) for Severe Alcohol Withdrawal Syndrome (AWS) and Alcohol Withdrawal Delirium (AWD) (clinicaltrials.gov) - Feb 10, 2016
P4, N=49, Terminated, Sponsor: Denver Health and Hospital Authority
N=569 --> 0 | Not yet recruiting --> Withdrawn N=150 --> 49 | Recruiting --> Terminated; DSMB recommendation for slow enrollment
- lorazepam / Generic mfg., dexmedetomidine / Generic mfg.
Clinical: Dexmedetomidine (Precedex®) for Severe Alcohol Withdrawal Syndrome (AWS) and Alcohol Withdrawal Delirium (AWD) (clinicaltrials.gov) - May 5, 2015
P4, N=150, Recruiting, Sponsor: Denver Health and Hospital Authority
N=150 --> 49 | Recruiting --> Terminated; DSMB recommendation for slow enrollment Trial primary completion date: Mar 2015 --> Mar 2017
- lorazepam / Generic mfg., dexmedetomidine / Generic mfg.
Clinical: Dexmedetomidine (Precedex®) for Severe Alcohol Withdrawal Syndrome (AWS) and Alcohol Withdrawal Delirium (AWD) (clinicaltrials.gov) - Apr 4, 2012
P4, N=150, Recruiting, Sponsor: Denver Health and Hospital Authority
Trial primary completion date: Mar 2015 --> Mar 2017 Initiation date: Aug 2011 --> Mar 2012
- lorazepam / Generic mfg., dexmedetomidine / Generic mfg.
Clinical: Dexmedetomidine (Precedex®) for Severe Alcohol Withdrawal Syndrome (AWS) and Alcohol Withdrawal Delirium (AWD) (clinicaltrials.gov) - Apr 4, 2012
P4, N=150, Recruiting, Sponsor: Denver Health and Hospital Authority
Initiation date: Aug 2011 --> Mar 2012 Not yet recruiting --> Recruiting